Table 2. βB2-crystallin in African-American and non-African-American cancer patients.

Types	Number	Regulated in African-American	Comparison items between African-American and Non-African-American	Outcome in African-American	References
Breast cancer	52	up-regulated	age, size, grade, stage, ER status, subtype	poor	[108]
Breast cancer	161	up-regulated	age and stage	poor	[110]
Breast cancer	108	up-regulated	age, size, grade, ER status, subtype	poor	[109]
Colorectal Cancer	126	up-regulated	age, gender, location, stage	no mention	[112]
Prostate cancer	69	up-regulated	source, stage, gleason sum score, seminal vesicle invasionc, surgical margin status	no mention	[103]
Prostate cancer	527	up-regulated	age, PSA, family history	poor	[113]
Renal cell carcinoma	116	up-regulated	patients, performance score, smoking status, tumor laterality, clinical, pathologic	no mention	[115]
Glioblastoma	995	up-regulated	age, gender, KPS, histological type, G-CIMP status, person neoplasm cancer status, history of neoadjuvant treatment, targeted molecular therapy, radiation therapy, ethnicity	well (under the condition of KPS ≥ 80)	[114]